
News|Articles|January 1, 2006
Pipeline Preview
Methylphenidate transdermal patch (Daytrana, Shire/Noven) to treat attention-deficit/hyperactivity disorder (ADHD)
Advertisement
Recommendations for approval
Approvable designations
Fast-track designation
Priority review
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement



















































